January 2002
Royal Society of Medicine: Medicines;2002, p347
Reference Entry
This article presents information on Marvelon, a proprietary, prescription-only compound preparation than can be used as oral contraceptives of the COC type that combines an estrogen and progesterone, in this case ethinylestradiol and desogestrel. It is available as tablets.


Related Articles

  • BiNovum.  // Royal Society of Medicine: Medicines;2002, p115 

    The article presents information on BiNovum, a proprietary, prescription-only compound preparation which can be used as a oral contraceptive of the COC type that combines an estrogen and a progesterone. This drug combines ethinylestradiol and norethisterone and is available as tablets in a...

  • oral contraceptive (Major drug group).  // Royal Society of Medicine: Medicines;2002, p412 

    The article presents information on oral contraceptive which refers to any of several prophylactic (preventive) sex hormone preparations which are taken by women to prevent conception following sexual intercourse and are commonly referred to as the Pill. The majority of oral contraceptives...

  • Drospirenone for Oral Contraception and Hormone Replacement Therapy: Are its Cardiovascular Risks and Benefits the Same as Other Progestogens? Motivala, Apurva; Pitt, Bertram // Drugs;2007, Vol. 67 Issue 5, p647 

    The use of combined estrogen/progesterone has been shown to result in an increased cardiovascular risk in randomised double-blinded trials. However, these studies used oral progestogen (progestin) preparations, which lack anti-mineralo-corticoid activity and have suboptimal anti-androgenic...

  • Estradiol Valerate/Dienogest: In Oral Contraception. Hoy, Sheridan M.; Scott, Lesley J. // Drugs;Aug2009, Vol. 69 Issue 12, p1635 

    â–´ Estradiol valerate/dienogest is an oral contraceptive for women that combines the natural estrogen estradiol with the 19-nortestosterone derivative dienogest in a four-phasic formulation. â–´ Estradiol valerate/dienogest demonstrated contraceptive efficacy in a large (n=1377),...

  • TriNovum.  // Royal Society of Medicine: Medicines;2002, p549 

    The article provides information on trinovum which can be used as an oral contraceptive of the combined oral contraceptive type that combines an oestrogen and a progestogen. It is available as tablets in a calendar pack.

  • Estrogen and Thromboembolic Disorders: Should Patients Stop Hormones Prior to Cosmetic Surgery? Shiffman, Melvin A. // Journal of Women's Health (15409996);Nov2003, Vol. 12 Issue 9, p853 

    Oral contraceptives and replacement estrogenic hormones have been associated with a significant risk of thromboembolism. Cosmetic surgery consists of elective procedures in otherwise healthy individuals. The prospect of thromboembolism should be diminished in these patients by avoiding those...

  • Oral contraceptive use among women aged 15 to 49: Results from the Canadian Health Measures Survey. Rotermann, Michelle; Dunn, Sheila; Black, Amanda // Health Reports;Oct2015, Vol. 26 Issue 10, p21 

    Background: Oral contraceptives (OCs) have been available in Canada for over 50 years and are the most commonly used method of reversible contraception. OCs have evolved over time, with decreasing estrogen doses, new progestins, and different dosing regimens. Detailed data about OC use among...

  • withdrawal bleeding. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p806 

    An encyclopedia entry for "withdrawal bleeding" is presented. It refers to the vaginal blood loss which occurs when the level of oestrogen or progesterone hormones or progestogen drugs in the body drops suddenly. A comparison between menstruation and withdrawal bleeding as a result of combined...

  • Effects of two types of hormonal contraceptionoral versus intravaginalon the sexual life of women and their partners. Maurizio Guida; Attilio Di Spiezio Sardo; Silvia Bramante; Stefania Sparice; Giuseppe Acunzo; Giovanni Antonio Tommaselli; Costantino Di Carlo; Massimiliano Pellicano; Elena Greco; Carmine Nappi // Human Reproduction;Apr2005, Vol. 20 Issue 4, p1100 

    BACKGROUND: Data relating to the influence of hormonal contraception on sexual life are conflicting and mostly they refer to oral contraceptives. In this randomized, controlled, prospective study we compared the effect of an intravaginal hormonal contraceptive with the effect of a combined oral...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics